The Promise of Generative AI in Reducing Animal Testing
Researchers are investigating how generative AI could potentially decrease the reliance on animal experiments in drug development, addressing ethical concerns.
Researchers are investigating how generative AI could potentially decrease the reliance on animal experiments in drug development, addressing ethical concerns.
The emotional toll of losing a pet extends beyond humans, affecting surviving animals as well. This piece reflects on the grief experienced by both parties.
As incidents of fires linked to improper battery disposal increase, states are debating who should bear the financial responsibility for managing this hazardous waste.
Recent reports indicate that significantly fewer seniors are utilizing expensive Alzheimer's medications than initially anticipated by Medicare.
Recent developments in biotech include Astellas' promising treatment for rare diseases, amid challenges in Alzheimer's drug rollout and insights from a China-based heart drug startup.
Adwoa Beauty has officially announced its shift to liquidation after converting its bankruptcy status to Chapter 7, marking a significant change for the company.
Recent polling indicates that a significant portion of the public is worried about the implications of immigration enforcement in hospitals, especially in light of recent policy changes.
This piece delves into how menstrual cycles may influence mental well-being, a topic that warrants further exploration.
A skin disease typically affecting livestock has been diagnosed in several men who have sex with men across Europe, according to recent findings by researchers.
Following a challenging period marked by both remarkable recoveries and tragic losses, Astellas is revisiting its gene therapy approach for XLMTM, offering renewed hope to affected families.
Following the sale of his company for $1.7 billion, an owner has decided to distribute $240 million among 540 dedicated employees who remained with the firm.
In a significant policy shift, a major US health provider has announced the removal of prior authorization requirements for 30% of services, a move that 93% of doctors believe is overdue.
Spanish authorities are gearing up to evacuate over 140 individuals from a cruise ship affected by hantavirus as it approaches the Canary Islands.
As the hantavirus outbreak progresses, experts express concern regarding the CDC's diminished involvement, with the WHO taking the lead in the response efforts.
In a recent discussion, Dr. Glaucomflecken highlights the necessity of maintaining local medical practices to better serve patients and communities, urging for national attention on the issue.
A new sensor, comparable in size to a grain of rice, promises to significantly improve the functionality of robots and medical devices by measuring forces and twisting motions using light.
The potential dismissal of FDA Commissioner Makary could lead to another significant vacancy within RFK Jr.'s health department, raising questions about future leadership.
Capricor Therapeutics has raised concerns about Nippon Shinyaku and its U.S. branch regarding the implementation of a treatment for Duchenne muscular dystrophy.
Recent findings highlight the potential of nanoparticles in fighting drug-resistant cancer, offering new hope for improving chemotherapy outcomes through advanced treatment methods.
Today's biotech news highlights a lawsuit concerning Duchenne therapy and challenges faced by FDA Commissioner Marty Makary in relation to the White House.